The DRRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DRRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The DRRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View DRRX Detailed Price Forecast - CNN Money||View DRRX Detailed Summary - Google Finance|
|View DRRX Detailed Summary - Yahoo! Finance||View DRRX Stock Research & Analysis - Zacks.com|
|View DRRX Trends & Analysis - Trade-Ideas||View DRRX Major Holders - Barrons|
|View DRRX Call Transcripts - NASDAQ||View DRRX Breaking News & Analysis - Seeking Alpha|
|View DRRX Annual Report - CompanySpotlight.com||View DRRX OTC Short Report - OTCShortReport.com|
|View DRRX Fundamentals - TradeKing||View DRRX SEC Filings - Bar Chart|
|View Historical Prices for DRRX - The WSJ||View Performance/Total Return for DRRX - Morningstar|
|View the Analyst Estimates for DRRX - MarketWatch||View the Earnings History for DRRX - CNBC|
|View the DRRX Earnings - StockMarketWatch||View DRRX Buy or Sell Recommendations - MacroAxis|
|View the DRRX Bullish Patterns - American Bulls||View DRRX Short Pain Metrics - ShortPainBot.com|
|View DRRX Stock Mentions - StockTwits||View DRRX Stock Mentions - PennyStockTweets|
|View DRRX Stock Mentions - Twitter||View DRRX Investment Forum News - Investor Hub|
|View DRRX Stock Mentions - Yahoo! Message Board||View DRRX Stock Mentions - Seeking Alpha|
|View Insider Transactions for DRRX - SECform4.com||View Insider Transactions for DRRX - Insider Cow|
|View DRRX Major Holdings Summary - CNBC||View Insider Disclosure for DRRX - OTC Markets|
|View Insider Transactions for DRRX - Yahoo! Finance||View Institutional Holdings for DRRX - NASDAQ|
|View DRRX Stock Insight & Charts - FinViz.com||View DRRX Investment Charts - StockCharts.com|
|View DRRX Stock Overview & Charts - BarChart||View DRRX User Generated Charts - Trading View|
DURECT Corporation to Host Key Opinion Leader Call on Alcoholic Hepatitis
Posted on Thursday March 29, 2018
CUPERTINO, Calif., March 29, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced it will host a key opinion leader (KOL) call on the treatment of alcoholic hepatitis (AH) on Thursday, April 5 at 11:00 a.m. Eastern Time. The call will feature a presentation by KOL Paul Kwo, MD, who will present an overview of alcoholic hepatitis, including an overview of the disease and its progression, current treatment options and new treatments in development for alcoholic hepatitis. Dr. Kwo will be available to answer questions at the conclusion of the call. DURECT's management team will also provide an overview of the Company's ongoing clinical development program for DUR-928, including a summary of preclinical and clinical data disclosed to-date and a review of the Company's Phase 2 study in patients with alcoholic hepatitis. DUR-928 is the lead product candidate in DURECT's Epigenetic Regulator Program. It is an endogenous, first-in-class small molecule that has been shown in nonclinical studies to modulate the activity of nuclear receptors playing an important regulatory role in lipid homeostasis, inflammation, and cell survival.
Investor Expectations to Drive Momentum within Aon plc, Endeavour Silver, BlackBerry, DURECT, Castle Brands, and Nabors Industries — Discovering Underlying Factors of Influence
Posted on Monday March 26, 2018
NEW YORK, March 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
Posted on Tuesday March 20, 2018
CUPERTINO, Calif. , March 20, 2018 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that its licensee, Pain Therapeutics (Nasdaq: PTIE), reported yesterday that the U.S. Food and Drug ...
Is DURECT Corporation (NASDAQ:DRRX) Undervalued?
Posted on Monday March 12, 2018
DURECT Corporation (NASDAQ:DRRX), a pharmaceuticals company based in United States, led the NasdaqGM gainers with a relatively large price hike in the past couple of weeks. As a small capRead More...